US$1.3M expansion opens US markets to vivoPharm

Based at the Hershey Center for Applied Research in Hershey, Pennsylvania, the company’s new, dedicated U.S. facilities, including laboratory and office space, are expected to open in September 2011.

The financial support, including cash and laboratory fit-out allowances, was obtained from Wexford Equities – developers of the Hershey Center.

“vivoPharm has identified key markets in the United States where demand for its preclinical services targeting the pharmaceutical and biotechnology industries is growing,” said Dr Fernando Felquer, Vice President, Business Development at vivoPharm Pty Ltd.

“The new facility at the Hershey Center for Applied Research puts vivoPharm in an ideal position to provide dedicated state-of-the-art services to the biotech and pharma industry not only in the East Coast biotechnology corridor but also to the rest of the United States and Canada.”

The U.S. facilities will add to vivoPharm’s international presence, which has grown since it established vivoPharm Europe two years ago.

“The establishment of laboratories in Pennsylvania takes vivoPharm closer to becoming a global player,” said Dr Brandt vivoPharm’s Managing Director and CEO.

“We first heard about opportunities in Pennsylvania four years ago, when Bio Innovation SA introduced us to Angela Foley, the Pennsylvania investment representative in Sydney.”

“We are delighted to be part of moves to grow bioscience capability in the United States while showcasing vivoPharm’s excellent and globally acknowledged service. We have experienced rapid expansion and are continuing to grow a global, Australian company.”

Next Article